UMIN-CTR History

UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials


Unique ID issued by UMIN UMIN000005836
Receipt No. R000006896
Scientific Title Phase I study of DCs therapy encoding mRNA derived from cancer antigens targeting advanced HCC & pancreatic cancer.
Date of disclosure of the study information 2011/06/26
Last modified on 2012/04/10 16:31:23

No. Disposal Last modified on Item of update
1 Insert 2011/06/22 17:28:34
2 Update 2011/06/28 18:27:29 Public title
3 Update 2011/06/28 18:29:36 Condition
Narrative objectives1
Primary outcomes
4 Update 2011/06/28 18:31:56 Key inclusion criteria
Key inclusion criteria
Key exclusion criteria
Key exclusion criteria
5 Update 2011/06/28 18:32:50 Post marketing survey by drug manufacture etc., specified by Japanese law.
6 Update 2011/06/28 18:36:37 Primary outcomes
7 Update 2012/04/10 16:31:23 Recruitment status

Contact us.